been achieved on a column packed with (R)-N-(3,5-dinitro-
benzoyl)phenylglycine, ionically bonded to R-aminopro-
pylsilanized silica (Regis Pirkle I-A).7,8 On the basis of
this result, the separation of BaP dihydrodiol, as well as
the 6-fluoro analogue was attempted on the Regis Pirkle
I-A column. Although the BaP dihydrodiol enantiomers
separated as reported, the 6-fluoro BaP dihydrodiol
enantiomers did not.
Eva lu a tion of th e En a n tiom er ic Resolu tion
of 7,8-Dih yd r oxy-7,8-d ih yd r oben zo[a ]-
p yr en e a n d Its 6-F lu or o a n d 6-Br om o
Der iva tives on P olysa cch a r id e-Der ived
Sta tion a r y P h a ses
Barbara Zajc,*,†,‡ Rok Grahek,§ Andrej Kocijan,§
Mahesh K. Lakshman,‡ J anez Kosˇmrlj,† and J ure Lah†
This led us to investigate other commercially available
columns for the separation of the 6-fluoro BaP dihy-
drodiol. Although other amino acid-based columns are
commercially available, we were surprised to find that
no studies on the separation of dihydrodiol or other PAH
metabolites have been reported using polysaccharide-
based columns, despite their various successful applica-
tions.14-20 Excellent separation of the (()-trans-7,8-dihy-
drodiol of 6-fluoro-BaP on a Daicel Chiralcel OG column4
initiated our present investigation.
Among the commercially available cellulose-based Da-
icel columns, three were chosen for the study: Chiralcel
CA-I (microcrystalline cellulose triacetate), Chiralcel OG
and OF (phenylcarbamate derivatives of cellulose coated
on silica gel). As substrates, 6-H-BaP-DHD, 6-F-BaP-
DHD and 6-Br-BaP-DHD (Figure 1) were chosen. These
close structural analogues offer conformational diversity,
which can be valuable in understanding chiral recogni-
tion. In the C-6 protio analogue, the hydroxyls are
predominantly quasi-diequatorial, while in the C-6 halo
analogues, these are predominantly quasi-diaxial. The
syntheses of BaP dihydrodiol21 and the C-6 fluoro ana-
logue4 have been reported, while the C-6 bromo analogue
was synthesized from 6-bromo-9,10-dihydrobenzo[a]py-
rene4 (see Supporting Information). (()-6-Br-BaP-DHD
Faculty of Chemistry and Chemical Technology, University
of Ljubljana, 1000 Ljubljana, Slovenia, Department of
Chemistry, The City College of CUNY, 138th Street at
Convent Avenue, New York, New York 10031, and
Lek Pharmaceutical Company, Research and
Development, 1526 Ljubljana, Slovenia
barbaraz@sci.ccny.cuny.edu
Received September 16, 2002
Abstr a ct: The enantiomeric resolution and the elution
order of (()-trans-7,8-dihydrodiols of benzo[a]pyrene and its
6-fluoro and 6-bromo derivatives were analyzed on three
polysaccharide-based columns: Daicel Chiralcel CA-I (cel-
lulose triacetate), OF, and OG [cellulose tris(4-chloro- and
4-methylphenylcarbamate)]. For comparison, the separation
of (()-1,1′-bi-2-naphthol was evaluated on the OG and OF
columns. Possibly similar interactions of (S)-1,1′-bi-2-naph-
thol and (7S,8S)-isomers of 6-halo-7,8-dihydroxy-7,8-dihy-
drobenzo[a]pyrene with the chiral sorbent are suggested.
Benzo[a]pyrene (BaP) is a known environmental pol-
lutant1 that is metabolized to carcinogenic bay-region diol
epoxides via dihydrodiols. Introduction of a halo sub-
stituent into position 6 of the BaP system dramatically
affects its tumorigenic properties, resulting in diminished
activity.2 The peri C-6 substituent also influences the
conformation of the dihydro and the tetrahydro ring in
the dihydrodiol and diol epoxide metabolites. Thus,
among the dihydrodiols, a preference for the quasi-diaxial
orientation of vicinal hydroxyl groups is observed in the
6-bromo3 and 6-fluoro4 7,8-dihydrodiols, whereas in the
6-H analogue, these are quasi-diequatorial. Also, among
the diol epoxides, the (7R,8S)-diol (9S,10R)-epoxide of
BaP is a potent tumorigen, whereas a lack of tumorigenic
activity has been reported for the 6-fluoro analogue.5 This
has been attributed to the conformational differences.
Recently, the synthesis of the (()-trans-7,8-dihydrodiol
of 6-fluoro-benzo[a]pyrene was reported.4 In light of the
small quantities needed, direct resolution by chiral HPLC
was preferred, rather than via diastereomer separation.6
Separation of dihydro and tetrahydrodiol derivatives of
several polycyclic aromatic hydrocarbons (PAHs) has
been extensively studied on amino acid-based enantiose-
lective columns.7-13 Resolution of BaP dihydrodiol has
(5) J erina, D. M.; Sayer, J . M.; Agarwal, S. K.; Yagi, H.; Levin, W.;
Wood, A. W.; Conney, A. H.; Pruess-Schwartz, D.; Baird, W. M.; Pigott,
M. A.; Dipple, A. Biological Reactive Intermediates III; Kocsis, J . J .,
J ollow, D. J ., Witmer, C. M., Nelson, J . O., Snyder, R., Eds.; Plenum
Press: New York, 1986; pp 11-30.
(6) Lakshman, M. K.; Chaturvedi, S.; Kole, P. L.; Windels, J . H.;
Myers, M. B.; Brown, M. A. Tetrahedron: Asymmetry 1997, 8, 3375-
3378 and references therein.
(7) Weems, H. B.; Yang, S. K. Anal. Biochem. 1982, 125, 156-161.
(8) Yang, S. K.; Weems, H. B.; Mushtaq, M.; Fu, P. P. J . Chromatogr.
1984, 316, 569-584.
(9) Yang, S. K.; Mushtaq, M.; Fu, P. P. J . Chromatogr. 1986, 371,
195-209.
(10) Weems, H. B.; Mushtaq, M.; Fu, P. P.; Yang, S. K. J . Chro-
matogr. 1986, 371, 211-225.
(11) Yang, S. K.; Mushtaq, M.; Weems, H. B.; Fu, P. P. J . Liq.
Chromatogr. 1986, 9, 473-492.
(12) Weems, H. B.; Fu, P. P.; Yang, S. K. Carcinogenesis 1986, 7,
1221-1230.
(13) Weems, H. B.; Yang, S. K. J . Chromatogr. 1990, 535, 239-253.
(14) Ichida, A.; Shibata, T.; Okamoto, I.; Yuki, Y.; Namikoshi, H.;
Toga, Y. Chromatographia 1984, 19, 280-284.
(15) Fukui, Y.; Ichida, A.; Shibata, T.; Mori, K. J . Chromatogr. 1990,
515, 85-90.
(16) Oguni, K.; Oda, H.; Ichida, A. J . Chromatogr. A 1995, 694, 91-
* Corresponding author. Phone: (212) 650-8926. Fax: (212) 650-6107.
† University of Ljubljana.
100.
(17) (a) Yashima, E.; Okamoto, Y. Bull. Chem. Soc. J pn. 1995, 68,
3289-3307. (b) The effect of the substituents on the adsorption
properties of 4-substituted phenylcarbamate CSPs was quantitatively
evaluated by plotting the retention times of acetone and of the first-
eluted isomer of 2,2,2-trifluoro-1-(9-anthryl)ethanol against the Ham-
mett σp substituent values.
‡ The City College of CUNY.
§ Lek Pharmaceutical Company.
(1) Harvey, R. G. Polycyclic Aromatic Hydrocarbons: Chemistry and
Carcinogenicity; Cambridge University Press: Cambridge, 1991.
(2) Cavalieri, E.; Rogan, E.; Cremonesi, P.; Higginbotham, S.;
Salmasi, S. J . Cancer Res. Clin. Oncol. 1988, 114, 10-15.
(3) Fu, P. P.; Yang, S. K. Biochem. Biophys. Res. Commun. 1982,
109, 927-934.
(18) Yashima, E.; Yamamoto, C.; Okamoto, Y. Synlett 1998, 344-360.
(19) Okamoto, Y.; Yashima, E. Angew. Chem., Int. Ed. 1998, 37,
1020-1043.
(4) Zajc, B. J . Org. Chem. 1999, 64, 1902-1907.
(20) Okamoto, Y.; Kaida, Y. J . Chromatogr. A 1994, 666, 403-419.
10.1021/jo020607t CCC: $25.00 © 2003 American Chemical Society
Published on Web 03/20/2003
J . Org. Chem. 2003, 68, 3291-3294
3291